These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Ophthalmic manifestations of rheumatologic disease: diagnosis and management. Petris CK; Almony A Mo Med; 2012; 109(1):53-8. PubMed ID: 22428448 [TBL] [Abstract][Full Text] [Related]
23. [Symptomatic eye changes during the course of sarcoidosis]. Cieślicka E; Cieślicki J; Ziora D; Romaniuk W; Oklek K Klin Oczna; 1998; 100(3):179-83. PubMed ID: 9814004 [TBL] [Abstract][Full Text] [Related]
24. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 10. Eye]. Kawashima H Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2607-12. PubMed ID: 24400541 [No Abstract] [Full Text] [Related]
31. The painful eye. Dargin JM; Lowenstein RA Emerg Med Clin North Am; 2008 Feb; 26(1):199-216, viii. PubMed ID: 18249263 [TBL] [Abstract][Full Text] [Related]
32. [New possibilities in therapy of ocular inflammation in rheumatic diseases]. Razumova IY; Godzenko AA Vestn Oftalmol; 2022; 138(6):108-114. PubMed ID: 36573954 [TBL] [Abstract][Full Text] [Related]
33. [Therapeutic implications of ocular involvement in systemic degenerative diseases]. Pinto G; Grasso L; Motolese E Clin Ter; 1984 Mar; 108(5):427-31. PubMed ID: 6232080 [No Abstract] [Full Text] [Related]
40. Oxidative stress and the eye. Williams DL Vet Clin North Am Small Anim Pract; 2008 Jan; 38(1):179-92, vii. PubMed ID: 18249249 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]